Keywords: اینترلوکین -23; a7-nAChR; alpha7-nicotinic acetylcholine receptor; Ang II; angiotensin II; AP; area postrema; AR; adrenergic receptor; AT1R; angiotensin type 1 receptor; AT2R; angiotensin type 2 receptor; AV3V; anteroventral third ventricle; BBB; blood-brain barrier; CNS
مقالات ISI اینترلوکین -23 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین -23; ANOVA; analysis of variance; BBB; blood-brain barrier; CCA; common carotid artery; Iba1; ionized calcium binding adaptor molecule 1; IFNγ; interferon gamma; IL-1β; interleukin-1β; IL-6; interleukin-6; IL-10; interleukin-10; IL-12; interleukin-12; IL-23
Keywords: اینترلوکین -23; Asthma; Eosinophils; Interleukin-17A; Interleukin-23; Th17BALF, bronchoalveolar lavage fluid; EDTA, ethylenediaminetetraacetic acid; ELISA, enzyme-linked immunosorbent assay; GAPDH, glyceradehyde-3-phosphate dehydrogenase; HDM, house dust mite; IFN-γ, int
Keywords: اینترلوکین -23; Enthesitis; Spondyloarthropathy; Interleukin-23; T lymphocytes
Keywords: اینترلوکین -23; Macrophages; Cytokines; Interleukin-10; Interleukin-12; Interleukin-23; Interferon-gamma; Transforming growth factor beta; Oral cancer; Squamous cell carcinoma;
IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment
Keywords: اینترلوکین -23; Psoriasis; Genetic polymorphism; Interleukin-23; Narrow-band ultraviolet B; Topical therapy;
Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway
Keywords: اینترلوکین -23; Gastric cancer; Interleukin-23; Interleukin-23 receptor; Epithelial-to-mesenchymal transition; Migration; Invasion;
Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats
Keywords: اینترلوکین -23; UC; ulcerative colitis; KJL; Kuijieling; Tregcells; regulatory T cells; Th17cells; T helper 17 cells; Foxp3; forkhead box P3; RORγt; retinoic acid-related orphan receptor γt; TGF-β1; transforming growth factor-β1; IL; interleukin; STAT; signal transdu
Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways
Keywords: اینترلوکین -23; Resolvin D1; Keratinocyte; Psoriasis; Inflammation; MAPKs; Boc; tert-butoxycarbonyl Met-Leu-Phe peptide; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; IL-17; interleukin-17; IL-22; interleukin-22; IL-23; interleukin-23; IMQ; imiquimod; MAPKs; mitogen-a
The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit
Keywords: اینترلوکین -23; Interleukin-12; Interleukin-23; Heparin; Heparan sulfate; P40 subunit; Docking calculations; BMP; bone morphogenetic protein; CS; chondroitin sulphate; FGF; fibroblast growth factor; FGFR; fibroblast growth factor receptor; GAG; glycosaminoglycan; GDNF; g
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, p
Keywords: اینترلوکین -23; adalimumab; efficacy; guselkumab; interleukin-23; psoriasis; safety; switching; VOYAGE 1; VOYAGE 2; AE; adverse event; DLQI; Dermatology Life Quality Index; IGA; Investigator Global Assessment; IL; interleukin; ISR; injection site reaction; MACE; major ad
Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease
Keywords: اینترلوکین -23; Ustekinumab; Crohn's disease; Inflammatory bowel disease; Interleukin-12/23 monoclonal antibody; Interleukin-12; Interleukin-23;
Short communicationSerum levels of TWEAK in patients with psoriasis vulgaris
Keywords: اینترلوکین -23; Tumor necrosis factor-related weak inducer of apoptosis; Tumor necrosis factor-alpha; Interleukin-6; Interleukin-23; Psoriasis;
Neutralization of IL-23 depresses experimental ocular neovascularization
Keywords: اینترلوکین -23; Interleukin-23; Ocular neovascularization; Tube formation; Angiogenic factors; NV; neovascularization; ROP; retinopathy of prematurity; VEGF; vascular endothelial growth factor; iNOS; inducible nitric-oxide synthase; OIR; oxygen-induced retinopathy; P; po
The IL-23/Th 17 pathway in spondyloarthritis: The Royal Road?
Keywords: اینترلوکین -23; Spondyloarthritis; Interleukin-23; Interleukin-17; Pathophysiology; Treatment;
Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves’ disease risk
Keywords: اینترلوکین -23; Interleukin-23; Single nucleotide polymorphism; Autoimmune disease; Graves’ disease
Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis
Keywords: اینترلوکین -23; Arthritis; Interleukin-17; Interleukin-23; T helper 17; Regulatory T cell;
IL12Rβ1: The cytokine receptor that we used to know
Keywords: اینترلوکین -23; Interleukin-12; Interleukin-23; il12rb1; Tuberculosis; Splicing;
Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway
Keywords: اینترلوکین -23; Mesenchymal stem cells; Autoimmune hepatitis; Programmed death ligand 1; Interleukin-17; Interleukin-23;
Specific targeting of interleukin-23p19 as effective treatment for psoriasis
Keywords: اینترلوکین -23; biologics; cytokines; efficacy; interleukin-12; interleukin-23; psoriasis; safety; IL; interleukin; IL-23R; interleukin-23 receptor complex; mRNA; messenger RNA; NK; natural killer; PsA; psoriatic arthritis; STAT; signal transducer and activator of transc
ReviewInterleukin 17A: Toward a new understanding of psoriasis pathogenesis
Keywords: اینترلوکین -23; cytokines; interleukin-17A; interleukin-23; keratinocytes; pathogenesis; psoriasis; T-helper 1Â cells; T-helper 17 cells; IL; interleukin; PASI; Psoriasis Area and Severity Index; Th; T helper; TNF; tumor necrosis factor;
Modulation of phenotypic and functional maturation of murine bone-marrow-derived dendritic cells (BMDCs) induced by cadmium chloride
Keywords: اینترلوکین -23; Cd2Â +; Cadmium; GM-CSF; granulocyte macrophage colony stimulating factor; IL-4; interleukin-4; IL-12; interleukin-12; IL-12Rb1 and IL-12Rb2; interleukin-12 receptor b1 and b2 subunit; IL-23; interleukin-23; BMDCs; bone-marrow-derived dendritic cells; APC
Up-regulation of interleukin-23 induces persistent allodynia via CX3CL1 and interleukin-18 signaling in the rat spinal cord after tetanic sciatic stimulation
Keywords: اینترلوکین -23; Cytokines; Glia; Interleukin-23; Neuropathic pain; Spinal dorsal horn; Tetanic stimulation of the sciatic nerve;
Update on Ustekinumab for the Treatment of Crohn's Disease
Keywords: اینترلوکین -23; Ustekinumab; Interleukin-12; Interleukin-23; Crohn's disease; Psoriasis; Interleukin-12/23 monoclonal antibody;
Involvement of levels of Toll like receptor-4 in monocytes, CD4 + T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura
Keywords: اینترلوکین -23; ITP; immune thrombocytopenic purpura; Th1; T helper 1 cells; Th17; T helper17 cells; IFN-γ; interferon-γ; IL-17; interleukin-17; TLR4; Toll like receptor-4; Th2; T helper2 cells; Treg; T regulator cells; IL-2; interleukin-2; IL-23; interleukin-23; immun
Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: Role in hepatitis B vaccine failure during hepatitis C infection
Keywords: اینترلوکین -23; ALT; alanine transaminase; AST; aspartate transaminase; HBV; hepatitis B virus; HBV-NR; hepatitis B vaccine non-responder; HBV-R; hepatitis B vaccine responder; HCV; hepatitis C virus; HIV; human immunodeficiency virus; HS; healthy subject; IL-12; interle
RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: Suppression by cilostazol
Keywords: اینترلوکین -23; CIA; collagen induced arthritis; IL-23; interleukin-23; LTA; lipoteichoic acid; RA; rheumatoid arthritis; TLR2; toll like receptor 2; RA synovial macrophages; RhoA; TLR2; IL-23; Cilostazol;
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis
Keywords: اینترلوکین -23; EAE; β-Lapachone; Microglia; Th17; Interleukin-23; Interleukin-17;
TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2
Keywords: اینترلوکین -23; DC; dendritic cell; FCS; fetal calf serum; GH; growth hormone; iE-DAP; γ-d-glutamyl-meso-diaminopimelic acid; LPS; lipopolysaccharide; MDP; muramyl dipeptide; moDCs; monocyte-derived DCs; NLR; NOD-like receptor; PGN; peptidoglycan; PRR; pattern recogniti
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease
Keywords: اینترلوکین -23; multiple sclerosis; experimental autoimmune encephalomyelitis; T helper cells; cytokines; granulocyte–macrophage colony-stimulating factor; interleukin-23; myeloid cells; macrophages; dendritic cells
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia
Keywords: اینترلوکین -23; Essential thrombocythemia; Polycythemia vera; JAK2 mutation; Interleukin-23; Interleukin-22; Interleukin-10
ssICAM-1, IL-21 and IL-23 in patients with tick borne encephalitis and neuroborreliosis
Keywords: اینترلوکین -23; Interleukin-21; Interleukin-23; ICAM-1; Tick borne encephalitis; Neuroborreliosis;
T helper type 17 in psoriasis: From basic immunology to clinical practice
Keywords: اینترلوکین -23; biologics; interleukin-17; interleukin-23; psoriasis; T helper type 17
Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis
Keywords: اینترلوکین -23; ankylosing spondylitis; C-reactive protein; erythrocyte sedimentation rate; interleukin-23; interleukin-17
KAP1/TRIM28: An inhibitor of IRF5 function in inflammatory macrophages
Keywords: اینترلوکین -23; DBD; DNA binding domain; H3K9me3; trimethylation of histone 3 at lysine 9; IAD; IRF association domain; IL12; Interleukin-12; IL23; Interleukin-23; IRF5; Interferon Regulatory Factor 5; KAP1; Krüppel-Associated Protein 1; LPS; lipopolysaccharide; NFκB;
Genetic variations in interleukin-12 related genes in immune-mediated diseases
Keywords: اینترلوکین -23; Interleukin-12; Interleukin-23; Interleukin-27; Interleukin-35; IL-12 polymorphism; Autoimmune disease; Cytokine; AID; autoimmune disease; AS; ankylosing spondylitis; CeD; celiac disease; CrD; Crohn's disease; GD; Graves disease; GWAS; genome-wide associa
Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway
Keywords: اینترلوکین -23; interferon-gamma; interleukin-12; interleukin-21; interleukin-23; lesional sarcoidosis; nonlesional sarcoidosis; cDNA; complementary DNA; CS; cutaneous sarcoidosis; CXCL; chemokine (C-X-C motif) ligand; FDR; false discovery rate; IFN; interferon; IL; inte
Efficacy and safety of ABT-874, a monoclonal anti–interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial
Keywords: اینترلوکین -23; ABT-874; interleukin-12; interleukin-23; plaque; psoriasis; Psoriasis Area and Severity Index; retreatmentAE, adverse event; EOW, every other week; IL, interleukin; PASI, Psoriasis Area and Severity Index; PASI 50, 50% or greater reduction in Psoriasis Ar
Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease
Keywords: اینترلوکین -23; Interleukin-12; Interleukin-23; Interleukin-27; Infection; Mycobacteria
Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases
Keywords: اینترلوکین -23; 5-ASA; 5-aminosalicylic acid; CAPE; caffeic acid phenethyl ester; DHA; docosahexaenoic acid; DMEM; Dulbecco's modified Eagle's medium; EGCG; epigallocatechin gallate; GAPDH; glyceraldehyde-3-phosphate-dehydrogenase; IBD; inflammatory bowel disease; IFN-γ
Expression and role of interleukin-23 in human endometrium throughout the menstrual cycle and early pregnancy
Keywords: اینترلوکین -23; Interleukin-23; Menstrual cycle; Decidua; Endometrium;
IL-23 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-κB signal pathways
Keywords: اینترلوکین -23; Interleukin-23; Human fibroblast-like synoviocytes; RANKL; Autoimmune arthritis; STAT3/NF-κB
Identification of single nucleotide polymorphisms in the bovine interleukin-12 and interleukin-23 receptor genes and their associations with health and production traits in Holstein cows
Keywords: اینترلوکین -23; interleukin-12; interleukin-23; somatic cell score; production trait;
Targeting IL-17 and Th17 Cells in Rheumatoid Arthritis
Keywords: اینترلوکین -23; Cytokines; T-cell differentiation; Biologic therapeutics; Interleukin-6; Interleukin-23; Interleukin-17;
Role of Nod2 in the development of Crohn's disease
Keywords: اینترلوکین -23; Crohn's disease; Inflammation; Homeostasis; Interleukin-10; Monocytes; Macrophages; Nod2; 1007fs; R702W; G908R; Interleukin-12; Interleukin-23; Mucosal immunity; TLR; Commensals
Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: Involvement of β-adrenoceptors and relevance in inflammatory diseases
Keywords: اینترلوکین -23; Sympathetic nervous system; Skin; Acquired inflammatory diseases; β-Adrenoceptors; Pattern recognition receptors; Interleukin-23; Plasmacytoid dendritic cells; Autoimmunity
TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells
Keywords: اینترلوکین -23; Dendritic; Interleukin-23; Toll-like receptor; TLR; LPS; CpG; Plasmacytoid; Myeloid; Langerhans; Interleukin-12; p19; p40; Splice variant
After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Keywords: اینترلوکین -23; CD4+ T cells; Crohn's disease; Inflammatory bowel disease; Interleukin-17; Interleukin-23; ThIL-17 cells; Ulcerative colitis
Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion
Keywords: اینترلوکین -23; Tumor necrosis factor; Experimental colitis; Inflammatory bowel disease; Interleukin-23; Interleukin-17IBD, inflammatory bowel disease; IFN, interferon; IL, interleukin; TNF, tumor necrosis factor; SCID, severe combined immune deficiency
TLR3 and TLR7 are involved in expression of IL-23 subunits while TLR3 but not TLR7 is involved in expression of IFN-β by Theiler's virus-infected RAW264.7 cells
Keywords: اینترلوکین -23; Interleukin-23; Interferon-β; TLR3, TLR7; Theiler's virusTMEV, Theiler's murine encephalomyelitis virus; MS, multiple sclerosis; DD, demyelinating disease; TLR, toll-like receptors; CNS, central nervous system; IFN, interferon; poly (I:C), polyinosine–pol